Some users may experience mild skin irritation or digestive discomfort, depending on individual sensitivities
Tirzepatide is a dual-action drug that targets both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
In one study 9 out of 12 subjects reported increased power output after exercise after taking 2 grams of L-Carnitine daily for five days
Additionally, this umbrella review focused only on comparisons between GLP-1 RAs and placebos or non-GLP-1 RA drugs, without directly comparing the efficacy among different GLP-1 RAs
Methods In this retrospective analysis of GLP-1RAs prescribed to patients with IBS at our institution from 2013-2023, we assessed the association of IBS subtype- and patient-related (age, race, body mass index, insurance, diabetes, gastroesophageal reflux disease) factors on the number and reasons for agent switches throughout the treatment course
His doctor called the body composition results exceptional for medication-assisted weight loss. 3